Global Biotechnology Market by Product Type (Instruments, Reagents and Services, and Software), By Technology (Nanobiotechnology, Tissue Engineering & Regents, DNA Sequencing, Cell-Based Assay, Fermentation, PCR Technology, Chromatography, and Other Technology), By Application (Healthcare, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, and Other Application), By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Jan 2024
- Report ID: 65847
- Number of Pages: 220
- Format:
-
keyboard_arrow_up
-
-
- AstraZeneca Plc Company Profile
- Gilead Sciences, Inc.
- Bristol-Myers Squibb
- Sanofi Company Profile
- Biogen
- Abbott Laboratories
- Pfizer, Inc.
- Amgen, Inc.
- Novo Nordisk A/S Company Profile
- Merck KGaA Company Profile
- Johnson & Johnson Services, Inc.
- Novartis AG Company Profile
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies Inc. Company Profile
- Danaher Corporation Company Profile
- Becton, Dickinson and Company Profile
- Bio-Rad Laboratories Inc.
- General Electric
- bioMérieux SA
- Lonza Group AG Company Profile
- Hoefer, Inc.
- PerkinElmer Inc.
- Promega Corporation
- Quality Biological
- Siemens Aktiengesellschaft Company Profile
- Bio-Techne
- Takara Holdings Inc. Company Profile
- Sysmex Corporation
- Tosoh Corporation
- Ortho Clinical Diagnostics
- Olympus Corporation
- Other Key Players
Our Clients
- 65847
- Jan 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
